Cambridge Epigenetix

Simultaneous genetic and epigenetic analysis solution

Cambridge, Massachusetts, United States

About Cambridge Epigenetix

biomodal's duet multiomics solution enables the simultaneous capture of genetic and epigenetic information from a single, low input DNA library, providing single-base-resolution, phased sequencing for enhanced biological insight in cancer, neurodegenerative disease, and ageing. The technology allows for the elucidation of greater biological insight without complex bioinformatics or harsh chemical treatment.

Cambridge, MA, USAHeadquarters
2012Year Founded
$158.1MTotal Funding
SERIES_DCompany Stage
Data & AnalyticsIndustries
51-200Employees